Medline Inc. (MDLN)

Revenue

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Front Line Care Revenue	6.09B	5.85B
Front Line Care Revenue Growth	4.16%	2.38%
Surgical Solutions Revenue	5.47B	4.93B
Surgical Solutions Revenue Growth	10.95%	10.91%
Laboratory and Diagnostics Revenue	956.00M	837.00M
Laboratory and Diagnostics Revenue Growth	14.22%	-0.83%
Medline Brand Revenue	12.52B	11.61B
Medline Brand Revenue Growth	7.77%	5.58%
Supply Chain Solutions Revenue	12.99B	11.62B
Supply Chain Solutions Revenue Growth	11.83%	11.19%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
United Stated Revenue	23.75B	21.80B
United Stated Revenue Growth	8.93%	9.19%
International Revenue	1.76B	1.43B
International Revenue Growth	22.99%	-3.51%

Adjusted EBITDA

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Medline Brand Adjusted EBITDA	3.27B	2.70B
Medline Brand Adjusted EBITDA Growth	20.89%	20.71%
Supply Chain Solutions Adjusted EBITDA	647.00M	491.00M
Supply Chain Solutions Adjusted EBITDA Growth	31.77%	0.20%

Updated undefined. Data Source: Fiscal.ai.